In vitro response of human gingival epithelial S-G cells to resveratrol

Toxicology Letters

Volumn 114, Issue 1-3, 2000, Pages 143-153

  Babich, H ^a   Reisbaum, A G ^a   Zuckerbraun, H L ^a  

^a YESHIVA UNIVERSITY   (United States)

Author keywords

Antioxidants; Cytotoxicity; Dental; In vitro alternatives; Phytochemicals; Resveratrol

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; BROXURIDINE; CYCLOPHOSPHAMIDE; HYDROGEN PEROXIDE; N ACETYL S NITROSOPENICILLAMINE; NEUTRAL RED; NITRIC OXIDE; OXIDOREDUCTASE; QUERCETIN; RESVERATROL;

ARTICLE; ASSAY; CARCINOMA CELL; CELL CULTURE; CELL SPECIFICITY; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; DOSE TIME EFFECT RELATION; DRUG SENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FIBROBLAST; GINGIVA; HUMAN; HUMAN CELL; KERATINOCYTE; LIVER MICROSOME; LYSOSOME; METABOLIC ACTIVATION; MITOCHONDRIAL RESPIRATION; MOUTH MUCOSA; OXIDATION REDUCTION STATE; PERIODONTAL LIGAMENT; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TONGUE TUMOR; TOOTH PULP;

ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; BROMODEOXYURIDINE; CARCINOMA, SQUAMOUS CELL; CELL COUNT; CELL DIVISION; CELL LINE; CELL SURVIVAL; COLORING AGENTS; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FIBROBLASTS; GINGIVA; HUMANS; INDICATORS AND REAGENTS; KERATINOCYTES; NEUTRAL RED; OXAZINES; STILBENES; TONGUE NEOPLASMS; XANTHENES;

VITACEAE;

EID: 0034599667     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(99)00288-X     Document Type: Article

References (45)

1. Babich, H., Tipton, D.A., 1999. In vitro cytotoxicity of bisphenol A to human gingival epithelial S-G cells. In Vitro Mol. Toxicol. (in press).
2. Babich H., Martin-Alguacil N., Borenfreund E. Mediating role of metabolic activation in in vitro cytotoxicity assays. Mol. Toxicol. 1:1987;363-372.
3. Babich H., Zuckerbraun H.L., Wurzburger B.J., Rubin Y.L., Borenfreund E., Blau L. Benzoyl peroxide cytotoxicity evaluated in vitro with the human keratinocyte cell line, RHEK-1. Toxicology. 106:1996;187-196.
4. Babich H., Zuckerbraun H.L., Hirsch S.T., Blau L. In vitro cytotoxicity of the nitric oxide donor, S-nitroso-N-acetyl-penicillamine, towards cells from human oral tissue. Pharmacol. Toxicol. 84:1999;218-225.
5. 0-ATPase, early target of the radical initiator, 2,2′-azobis-(2-amidinopropane) dihydrochloride in rat liver mitochondria in vitro. Biochem. J. 320:1996;571-576.
6. Belguendouz L., Fremont L., Linard A. Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem. Pharmacol. 53:1997;1347-1355.
7. Bertelli A.A.E., Giovannini L., Giannessi L., Stradi R., Bertelli A., Tillement J.P. Plasma, urine, and tissue levels of trans- and cis-resveratrol (3,4′,5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. Int. J. Tissue React. 18:1996;67-712.
8. Bertelli A., Bertlli A.A.E., Gozzini A., Giovannini L. Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exp. Clin. Res. 24:1998;133-138.
9. Borenfreund E., Babich H., Martin-Alguacil N. Rapid chemosensitivity assay with human normal and tumor cells in vitro. In Vitro Cell. Dev. Biol. 26:1990;1030-1034.
10. Carbo N., Costelli P., Baccino F.M., Lopez-Soriano F., Argiles J.M. Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem. Biophys. Res. Commun. 254:1999;739-743.
11. Chanvitayapongs S., Draczynska-Lusiak B., Sun A.Y. Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells. Neuroreport. 8:1997;1499-1502.
12. Chun Y.J., Kim M.Y., Guengerich F.P. Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem. Biophys. Res. Commun. 262:1999;20-24.
13. Clement M.-V., Hipara J.L., Chawdhury S.-H., Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood. 92:1998;996-1002.
14. Della Ragione F., Cucciolla V., Borriello A., Pietra V.D., Racioppi L., Soldati G., Manna C., Galletti P., Zappia V. Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochem. Biophys. Res. Commun. 250:1998;53-58.
15. ElAttar T.M.A., Virji A.S. Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation. Anticancer Res. 10:1999;187-193.
16. Fauconneau B., Waffo-Teguo P., Hugget F., Barrier L., Decendit A., Merillon J.-M. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci. 61:1997;2103-2110.
17. Fontecave M., Lepoivre M., Elleingand E., Gerez C., Guittet O. Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett. 421:1998;277-279.
18. Hsieh T.C., Wu J.M. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp. Cell Res. 249:1999;109-115.
19. Hsieh T.C., Burfeind P., Laud K., Backer J.M., Traganos F., Darzynkiewicz Z., Wu J.M. Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials. Int. J. Oncol. 15:1999a;245-252.
20. 1. Cancer Res. 59:1999b;2596-2601.
21. Huang C., Ma W., Goranson A., Dong Z. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis. 20:1999;237-242.
22. Jang M., Pezzuto J.M. Cancer chemopreventive activity of resveratrol. Drugs Exp. Clin. Res. 25:1999;65-77.
23. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W.W., Fong H.H.S., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:1997;218-220.
24. Jang D.-S., Kang B.-S., Ryu S.Y., Chang I.-M., Min K.R., Kim Y. Inhibitory effects of resveratrol analogs on unopsonized zymosan-induced oxygen radical formation. Biochem. Pharmacol. 57:1999;705-712.
25. Kasten F.H., Pineda L.F.R., Schneider P.E., Rawls H.R., Foster T.A. Biocompatibility testing of an experimental fluoride releasing resin using human gingival epithelial cells in vitro. In Vitro Cell. Dev. Biol. 25:1989;57-62.
26. Kasten F.H., Seileau K., Neffert R.M. Quantitative evaluation of human gingival epithelial cell attachment to implant surfaces in vitro. Int. J. Periodontol. Restor. Dent. 10:1990;69-79.
27. Kawada N., Seki S., Inoue M., Kuroki T. Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology. 27:1998;1265-1274.
28. Law A., Wu J., Zeng L.H., Wu T.W. Aortic endothelial cells damaged by a nitric oxide donor and protected by flavonoids. Life Sci. 64:1999;PL199-PL204.
29. Lord-Fontaine S., Averill D.A. Enhancement of cytotoxicity of hydrogen peroxide by hyperthermia in Chinese hamster ovary cells: role of antioxidant defenses. Arch. Biochem. Biophys. 363:1999;283-295.
30. Lu R., Serrero G. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. J. Cell. Physiol. 179:1999;297-304.
31. McMurtrey K.D. Resveratrol in wine. Watkins T. Wine, Nutritional and Therapeutic Benefits. 1996;44-55 American Chemical Society, Washington, DC.
32. Mgbonyebi O.P., Russo J., Russo I.H. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int. J. Oncol. 12:1998;865-869.
33. Mizutani K., Ikeda I., Kawai Y., Yamori Y. Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biochem. Biophys. Res. Commun. 253:1998;859-863.
34. Pace-Asciak C.R., Hahn S., Diamandis E.P., Soleas G., Goldberg D.M. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin. Chim. Acta. 235:1995;207-219.
35. Pace-Asciak C.R., Rounova O., Hahn S.E., Diamandis E.P., Goldberg D.M. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin. Chim. Acta. 246:1996;163-182.
36. Pendurthi U.R., Williams J.T., Rao L.V.M. Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells. Arterioscler. Thromb. Vasc. Biol. 19:1999;419-426.
37. Rawls H.R., Starr J., Kasten F.H., Murray M., Smid J., Cabasso I. Radiopaque acrylic resins containing miscible heavy metal compounds. Dent. Mater. 6:1990;250-255.
38. Rhim J.S., Jay G., Arnstein P., Price F.M., Sanford K.K., Aaronson S.A. Neoplastic transformation of human epidermal keratinocytes by Ad12-SV40 and Kirsten sarcoma viruses. Science. 227:1985;1250-1252.
39. Rotondo S., Ratjar G., Manarini S., Celardo A., Rotilio D., de Gaetano G., Evangelista V., Cerletti C. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Brit. J. Pharmacol. 123:1998;1691-1699.
40. Sanderson J., McLauchlan W.R., Williamson G.W. Quercetin inhibits hydrogen peroxide-induced oxidation of the rat lens. Free Radic. Biol. Med. 26:1999;639-645.
41. Soleas G.J., Diamandis E.P., Goldberg D.M. Resveratrol: a molecule whose time as come? And gone? Clin. Biochem. 30:1997;91-113.
42. Sun A.Y., Chen Y.M., James-Kracke M., Wixom P., Cheng Y. Ethanol-induced cell death by lipid peroxidation in PC12 cells. Neurochem. Res. 22:1997;1187-1192.
43. Sun N.J., Woo S.H., Cassady J.M., Snapka R.M. DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia. J. Nat. Prod. 61:1998;362-366.
44. Teel R.W., Huynh H. Modulation by phytochemicals of cytochrome P450-linked enzyme activity. Cancer Lett. 133:1998;135-141.
45. Tsai S.-H., Lin-Shiau S.-Y., Lin J.-K. Suppression of nitric oxide synthase and down-regulation of the activation of NFκB in macrophages by resveratrol. Brit. J. Pharmacol. 126:1999;673-680.